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ABSTRACT
Objectives: To study the long-term outcome of patients
with primary hyperaldosteronism who underwent laparo-
scopic adrenalectomy and to determine the preoperative
predictive factors of persistent hypertension.
Methods: Between 1996 and 2002, 47 patients with pri-
mary hyperaldosteronism underwent transperitoneal
laparoscopic adrenalectomy at our institution. Their clin-
ical and biochemical parameters were reviewed retro-
spectively, and the outcome of 46 patients with complete
follow-up notes were determined.
Results: The study comprised 16 male and 30 female
patients with a mean age of 45.6 years (range, 18 to 63
years). Almost all patients had hypertension and hypoka-
lemia at presentation, requiring medication. The average
operating time was 127 minutes (range, 70 to 240 min),
and the mean postoperative stay was 2.6 days (range, 1 to
5 days). No mortalities occurred, and perioperative mor-
bidity was minimal. Forty-two (91%) patients had adrenal
cortical adenoma (including 1 with both adenoma and
hyperplasia), and 4 (9%) had adrenal hyperplasia on his-
tology. The average follow-up time was 21 months (range,
1 to 60 months), and at the end of follow-up, all patients
had normal serum potassium levels without potassium
supplements. Twenty-three (50%) patients were cured of
hypertension, and 13 (28%) patients had better control of
their hypertension as evidenced by the decrease in the
number of antihypertensive medications used. On multi-
variate analysis, the age of the patient at surgery was
shown to be an independent predictive factor of persistent
hypertension after successful surgery.
Conclusion: Laparoscopic adrenalectomy is a safe and
effective way to treat primary hyperaldosteronism, espe-
cially in controlling hypokalemia and in the management
of hypertension. The age of a patient at surgery is an
independent preoperative risk factor of persistent hyper-
tension.
Key Words: Laparoscopy, Adrenalectomy, Hyperaldoste-
ronism, Conn’s syndrome.
INTRODUCTION
Although previously thought to be a rarity, primary hy-
peraldosteronism is now considered one of the most com-
mon causes of secondary hypertension. It occurs in ap-
proximately 1 in every 200 patients who are hypertensive
but constitutes one of the most common causes of surgi-
cally correctable hypertension.1 It was first described in
1955 by Jerome Conn as a syndrome characterized by
hypertension, hypokalemia, and excessive urinary excre-
tion of aldosterone in association with adrenal cortical
adenoma (Conn’s syndrome).2 However, we now know
that primary hyperaldosteronism may also be caused by
other adrenal pathologies, such as idiopathic adrenal hy-
perplasia or adrenal carcinoma.3
Aldosterone-producing adenoma is the most common
cause of primary hyperaldosteronism, and the treatment
of choice is adrenalectomy.4–8 Unilateral adrenalectomy
has also been shown to be the ideal treatment for patients
with unilateral sources of aldosterone secretion, such as
unilateral hyperplasia and adrenal carcinoma.8,9 For bilat-
eral adrenocortical hyperplasia, medical therapy with al-
dosterone antagonists, such as spironolactone, appears to
be the best treatment.1,10
Ever since the first laparoscopic adrenalectomy was per-
formed in 1992 by Gagner, this procedure has become the
treatment of choice and has replaced open surgery for the
removal of adrenal tumors.3,11 The transperitoneal laparo-
scopic approach most widely used today was pioneered
by Gagner in 1994, whereby the patient is placed in the
lateral decubitus position, which allows better exposure
of the adrenals.12 Laparoscopic adrenalectomy demon-
strates many benefits of minimally invasive surgery in-
cluding decreased postoperative pain, a shortened hospi-
talization, a more rapid convalescence, decrease in overall
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SCIENTIFIC PAPERcost and decreased morbidity with the smaller incisions
and shorter postoperative recovery time.4,7,13–19 Although
it has been well demonstrated in the literature that open
adrenalectomy is beneficial in patients with aldosterone
producing adenoma, long-term outcome after laparo-
scopic adrenalectomy has not been extensively studied.
The aim of our study was to evaluate the long-term out-
come of patients undergoing laparoscopic adrenalectomy
for hyperaldosteronism with particular attention to the
control of hypokalemia and hypertension and to deter-
mine the preoperative risk factors of persistent hyperten-
sion after successful surgery.
METHODS
From July 1996 to March 2002, 47 consecutive patients
underwent laparoscopic adrenalectomy for primary hy-
peraldosteronism at Singapore General Hospital. Patients’
medical records including the pathology and operative
reports were reviewed retrospectively, and the relevant
parameters were studied including the pre- and postop-
erative blood pressures and serum potassium levels. One
patient’s follow-up records were incomplete and ex-
cluded from the follow-up study. The outcome of 46
patients with complete follow-up records was determined
with particular attention to the control of blood pressure
and serum potassium levels.
All the patients had hypertension at presentation and 94%
had hypokalemia (n44). Patients with suspected hyper-
aldosteronism underwent some or all of the following
laboratory investigations including random serum aldoste-
rone and renin, 24-hour urine potassium excretion, and
24-hour urine aldosterone measured after salt loading. All
our patients had a computed tomography scan to localize
the adrenal adenoma. Postural studies and adrenal venous
sampling were only used when the diagnosis remained
uncertain after the above tests.
The surgical technique used for all our patients was the
transperitoneal approach via the flank with the patient in
the lateral decubitus approach as described previously.20
Preoperative risk factors of persistent hypertension stud-
ied included age of patient at surgery, sex, duration of
hypertension, systolic blood pressure, serum potassium
level, and size of adenoma.
Mann-Whitney U tests were used to compare continuous
variables, and chi-squared tests were used to compare
categorical variables. A stepwise multiple logistic regres-
sion analysis was performed to assess the combined pre-
dictive effects of the clinicopathologic variables. In this
analysis, outcome of hypertension was the dependent
variable; and the clinical, biochemical, and pathologic
variables were independent predictor variables. All statis-
tical procedures were performed using the computer soft-
ware SPSS for Windows Version 10.0.
RESULTS
Forty-six patients underwent surgery, and their demo-
graphic characteristics are summarized in Table 1. All the
patients were hypertensive, and 44 (96%) had hypokale-
mia at presentation. In general, most of the patients had
poorly controlled hypertension, and the mean duration of
hypertension before surgery was 6.7 years (range, 0 to 20
years).
On biochemical confirmation of hyperaldosteronism, a
computed tomography scan was successful in localizing
all the tumors except in 1 patient whose scan was
equivocal, and magnetic resonance imaging was used
to localize his tumor. Laparoscopic transperitoneal adre-
nalectomy was performed in all the patients and no con-
versions were necessary. Twenty-three patients under-
went left-sided and the rest had right-sided surgery. The
average operating time was 12736 minutes (range, 70 to
240 min), and the mean postoperative stay was 2.60.9
days (range, 1 to 5 days). No mortalities occurred, and the
only morbidity was superficial wound infection in 1 pa-
tient, which settled with antibiotic treatment and wound
dressing.
Histology revealed that 42 (91%) patients had cortical
adenomas (including 1 with concomitant adenoma and
hyperplasia) and 4 (9%) had adrenal hyperplasia. The
mean size of the adenomas was 1.9 0.7 cm (range, 0.7 to
3.7 cm).
Postoperative Follow-up
The average follow-up time of the 46 patients was 2119
months (range, 1 to 60 months). The functional outcome
Table 1.
Patient Demographics
No. of patients 46
Mean age (yrs) 45.6 (18–63)
Sex 16 M, 30 F
Hypertensive at presentation 46 (100%)
Hypokalemic at presentation 44 (96%)
Duration of hypt (yrs) 6.7 (0–20)
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patients had normal serum potassium levels without po-
tassium supplements. The mean potassium level at pre-
sentation of 2.4 mol/L (range, 1.4 to 3.5 mol/L) was
significantly lower than the mean postoperative potassium
levels of 4.3 mol/L (range, 3.7 to 5.1 mol/L) (P0.05).
At the end of follow-up, 23 patients (50%) were cured of
their hypertension, not requiring any medications for
blood pressure control. A further 13 (28%) had improved
control of their blood pressure as evidenced by the de-
crease in the number of antihypertensive medications
used. Of the remaining 10 patients (22%) who had persis-
tent hypertension requiring the same number of antihy-
pertensives, 8 (17%) had better control. This presumption
was made on the fact that these patients had lower mean
blood pressure after surgery, and they no longer required
frequent follow-up and adjustment of their medications.
At latest follow-up, the mean blood pressure (136/83 mm
Hg) was significantly lower than the preoperative mea-
surements (166/98 mm Hg, P0.0005). Patients in general
also required fewer antihypertensive medications after
surgery (mean, 11.1 antihypertensives) compared with
their preoperative requirements (mean, 2.10.9 antihy-
pertensives).
Table 3 summarizes the results of our analysis of the
possible preoperative risk factors of persistent hyperten-
sion. Univariate analysis showed that age at surgery and
duration of hypertension were statistically significant in
predicting postoperative persistent hypertension. Severity
of hypertension indicated by the number of antihyperten-
sives used was also statistically significant as a risk factor
of persistent hypertension. However, although a trend
was present toward the higher the systolic blood pressure
preoperatively, the more likely it was that the patient had
persistent hypertension, this only approached statistical
significance.
On multivariate analysis using stepwise logistic regres-
sion, only age at surgery was shown as an independent
risk factor of postoperative persistent hypertension. A
strong positive correlation existed between the duration
of hypertension and age at surgery (r0.45), which was
evident in the logistic model.
DISCUSSION
Laparoscopic adrenal surgery is undoubtedly the most
important advance in adrenal surgery over the last decade,
and its impact is such that it is currently the treatment of
choice for patients with various adrenal functional tumors
including aldosterone-producing adenoma. It has been
well documented that the laparoscopic procedure is safe
with substantially less morbidity than open surgery for
similar indications.7,13,14,21 The laparoscopic approach is
feasible in approximately 60% of surgically treatable ad-
renal disease.7 Classically, the contraindications to the
laparoscopic approach are large tumor size (6c mb e -
cause of the high likelihood of malignancy), local tumor
invasiveness or large primary adrenal malignancy.4,14,22
However, tumor size larger than 6 cm and adrenal malig-
nancy cannot be considered as absolute contraindications
now as several authors have advocated laparoscopic re-
moval of these tumors.23,24 Coagulopathy and previous
surgery or trauma to the region of the gland to be re-
moved are also relative contraindications to laparos-
copy.21
Table 2.
Comparison of Preoperative and Postoperative Patient Data*
Preoperative Postoperative P Value†
Mean Systolic BP (mm Hg) 16632 13620 .0005
Mean Diastolic BP (mm Hg) 9819 8214 .0005
Serum K (mol/L) 2.40.6 4.30.3 .0005
Hypertensive 46/46 (100%) 23/46 (50%) .0005
Mean No. of Medications 2.10.9 1.01.1 .0005
Hypertension Cured NA 23/46 (50%) NA
Hypertension Improved NA 44/46 (95%) NA
Normokalemia NA 46/46 NA
*NA  Data not available.
†Wilcoxon Signed Ranks test used to determine P value.
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scopic surgery without any conversions. The safety of the
procedure was well illustrated by the absence of mortality
and the minimal perioperative morbidity. However, de-
spite the obvious success of the laparoscopic approach
over the past decade, the long-term outcome of laparo-
scopic surgery in patients with primary hyperaldosteron-
ism has not been extensively studied. A review of the
literature revealed only a handful of outcome studies on
patients who underwent laparoscopic adrenalectomy for
primary hyperaldosteronism.3,24–29 All were smaller series
compared with the present report except for the recent
series by Meria et al.27 Overall, hypokalemia was cured in
96% to 100% of patients, whereas hypertension was cured
in 31% to 88% of patients.3,24–29 These results are compa-
rable to those of outcome studies in patients who under-
went open surgery whereby the cure rates of hypokalemia
were also close to 100%, and the hypertensive cure rates
ranged from 41% to 77%.5,6,30 In our series, all patients
were normokalemic, while 50% of patients were cured of
hypertension. Table 4 summarizes and provides a com-
parison between our study and 5 previous outcome stud-
ies on patients undergoing laparoscopic surgery.
Essential hypertension has been suggested as the reason
behind persistent hypertension after adrenalectomy.31
Several preoperative factors have been shown to be risk
factors for the development of persistent hypertension
after surgery, and these include older age of the patient at
surgery, longer duration of preoperative hypertension,
nonresponse of blood pressure to spironolactone, male
sex, and family history of hypertension. Table 5 summa-
rizes some of the studies evaluating preoperative predic-
tive factors of persistent hypertension. Although preoper-
ative blood pressure response to spironolactone has been
shown as a predictive factor, we were unable to evaluate
it as most of our patients were on other concomitant
antihypertensive medications preoperatively.6,31–33
Our univariate analysis revealed that duration of hyper-
tension preoperatively, age of patient at surgery, and se-
verity of preoperative hypertension were possible risk
factors of persistent hypertension. However, age at sur-
Table 3.
Analysis of Possible Preoperative Risk Factors of Persistent Hypertension*
Variable Normotensive (n  23) Hypertensive (n  23) Total P Value
Mean age at surgery (yrs) 41.210.85 50.18.7 NA 0.007
Mean duration of hypertension (yrs) 4.64.8 8.96.1 NA 0.01
No. of medications before operation 1.60.8 2.50.9 NA 0.002
Mean serum K (mmol/L) 2.30.5 2.60.6 NA 0.130
Size of adenoma (cm) 1.90.6 1.60.6 NA 0.168
Systolic blood pressure (mm Hg) 15627 17331 NA 0.06
Sex 6M, 17F 11M, 12F 17M, 29F 0.221
*NA  Data not available.
Table 4.
Comparison of Current Study With Previous Outcome Studies of Patients Undergoing Laparoscopic Adrenalectomy*
Study No. of
Patients
Age
(years)
Follow-up
(months)
Hypertension
Duration (years)
Normokalemia (%) Hypertension
Cured
Rossi25 30 51.2 26.1 NA 97 67
Brunt26 26 48 27.9 9.8 96 31
Shen3 42 50 NA 2.5 100 88
Bonjer24 26 NA 14 NA 100 64
Meria27 182 48 44 12 100 58
Current Study 46 45.6 21 6.7 100 50
*NA  Data not available.
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multiple stepwise logistic regression. Several studies
have shown that duration of hypertension preoperatively
is a risk factor of persistent postoperative hyperten-
sion.5,25,30,31,34 Irreversible vascular damage during long-
standing hypertension despite surgical cure of metabolic
derangement has been suggested as the reason why du-
ration of hypertension is a risk factor.35 Older age of the
patient at surgery has also been shown by previous stud-
ies to be a predictive factor of postoperative hyperten-
sion.6,31,32,36 The higher incidence of essential hyperten-
sion in older patients has been proposed as an important
reason why older age is a risk factor. Furthermore, it is
possible that older patients are more likely to have long-
standing hypertension and are more susceptible to the
irreversible hypertensive vascular changes.32 In fact, our
study suggests a strong correlation between the age of a
patient and the duration of hypertension.
Identification of patients at high risk for persistent hyper-
tension after successful surgery does not preclude them
from undergoing surgery, as the majority of them will
benefit from the procedure. However, identifying these
patients preoperatively is important as these patients can
be warned preoperatively of the slightly less favorable
outcome, and they should be followed up more closely
after surgery.
CONCLUSION
In summary, laparoscopic adrenalectomy is a safe and
effective procedure in the treatment of patients with pri-
mary hyperaldosteronism with a good outcome in terms
of hypokalemia and blood pressure control. Age of a
patient at surgery is an independent predictive factor of
persistent hypertension postoperatively.
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